Akeso Inc.

08/05/2021 | Press release | Distributed by Public on 08/04/2021 16:14

VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION FOR PENPULIMAB MONOCLONAL ANTIBODY (PD-1) FOR THIRD-LINE TREATMENT OF METASTATIC NASOPHARYNGEAL CARCINOMA ACCEPTED BY NMPA

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.